Coronavirus Anatomy and Its Analytical Approaches for Targeting COVID-19

Santheraleka Ramanathan1, M B Malarvili2, Subash C B Gopinath3,4,5

  • 1School of Biomedical Engineering, Universiti Teknologi Malaysia, UTM, 81310, Skudai, Johor, Malaysia.

Insights

The Coronavirus 2019 (COVID-19) pandemic spurred research into diagnostic and therapeutic tools. This chapter reviews molecular techniques for COVID-19 prognosis, discussing available methods and their limitations.

Area of Science:

  • Virology
  • Epidemiology
  • Molecular Diagnostics

Background:

  • The global Coronavirus 2019 (COVID-19) pandemic has necessitated rapid advancements in diagnostics and therapeutics.
  • Emerging variants of SARS-CoV-2 present ongoing challenges for effective treatment and control.
  • Understanding viral anatomy and dissemination is crucial for public health strategies and epidemic prediction.

Purpose of the Study:

  • To discuss the significance of molecular techniques in developing prognostic analytical methods for COVID-19.
  • To evaluate the advantages and limitations of current diagnostic and therapeutic approaches for COVID-19.

Main Methods:

  • Review of molecular techniques, including polymerase chain reaction (PCR) and antigen rapid tests.
  • Analysis of the role of molecular diagnostics in tracking the COVID-19 epidemic.
  • Examination of the scientific literature on antiviral therapies and vaccine development.

Main Results:

  • Widespread adoption of PCR and antigen tests has increased testing capacity.
  • Molecular techniques are vital for prognostic analysis and understanding COVID-19 progression.
  • Challenges remain in developing ideal diagnostic and therapeutic tools due to viral evolution.

Conclusions:

  • Molecular techniques offer significant potential for prognostic analysis of COVID-19.
  • A comprehensive understanding of viral characteristics and spread is essential for effective pandemic response.
  • Continued research is needed to overcome limitations and develop superior diagnostic and therapeutic solutions for COVID-19.